Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

ImageneBio, Inc., Common Stock

IMA

NAQ

$7.96

-$0.49

(-5.8%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$94.49M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

181.83K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$8.24 L

$23.28 H

$7.96

About ImageneBio, Inc., Common Stock

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. Its lead product includes IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for the treatment of atopic dermatitis and alopecia areata. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California. more

Returns

Data is not properly formatted.

Time Frame	IMA		S&P500
1-Week Return	-40.6%%	%	0.59%%
1-Month Return	-51.73%%	%	3.33%%
3-Month Return	-48.97%%	%	9.45%%
6-Month Return	-50.86%%	%	11.22%%
1-Year Return	-60.04%%	%	18.12%%
3-Year Return	-87.09%%	%	66.07%%
5-Year Return	-97.93%%	%	94.86%%

Financials

	Dec '23	Dec '24
Total Revenue	7.96M	3.50M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":43.96,"profit":true}]
Cost of Revenue	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	29.89M	40.50M	[{"date":"2023-12-31","value":73.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(21.93M)	(37.00M)	[{"date":"2023-12-31","value":-2192500000,"profit":false},{"date":"2024-12-31","value":-3700000000,"profit":false}]
Total Non-Operating Income/Expense	1.06M	445.00K	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":42.1,"profit":true}]
Pre-Tax Income	(20.87M)	(36.55M)	[{"date":"2023-12-31","value":-2086800000,"profit":false},{"date":"2024-12-31","value":-3655500000,"profit":false}]
Income Taxes	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(21.15M)	(36.57M)	[{"date":"2023-12-31","value":-2114800000,"profit":false},{"date":"2024-12-31","value":-3656800000,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(21.15M)	(36.57M)	[{"date":"2023-12-31","value":-2114800000,"profit":false},{"date":"2024-12-31","value":-3656800000,"profit":false}]

EPS (Diluted)	(19.62)	(12.24)	[{"date":"2023-12-31","value":-1961.6,"profit":false},{"date":"2024-12-31","value":-1224.26,"profit":false}]

	Dec '23	Dec '24
Total Revenue	-	(56.04%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Cost of Revenue	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	35.51%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	-	68.76%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	(57.90%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Pre-Tax Income	-	75.17%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	72.91%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	72.91%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	(37.59%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Dec '23	Dec '24
Total Assets
Current Assets	25.90M	12.47M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":48.14,"profit":true}]
Non-current Assets	5.35M	3.45M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":64.61,"profit":true}]
Total Assets	31.25M	15.92M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":50.96,"profit":true}]

Total Liabilities
Current Liabilities	9.49M	17.21M	[{"date":"2023-12-31","value":55.17,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	147.86M	159.28M	[{"date":"2023-12-31","value":92.83,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	157.35M	176.49M	[{"date":"2023-12-31","value":89.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	(143.33M)	(179.90M)	[{"date":"2023-12-31","value":-14333200000,"profit":false},{"date":"2024-12-31","value":-17990000000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	(126.11M)	(160.56M)	[{"date":"2023-12-31","value":-12610800000,"profit":false},{"date":"2024-12-31","value":-16056500000,"profit":false}]

Total Liabilities & Shareholders Equity	31.25M	15.92M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":50.96,"profit":true}]

	Dec '23	Dec '24
Total Assets
Current Assets	-	(51.86%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Non-current Assets	-	(35.39%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Total Assets	-	(49.04%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	81.26%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	-	7.72%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	-	12.16%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	25.51%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	27.32%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(49.04%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]


Total Assets
Current Assets	[]
Non-current Assets	[]
Total Assets	[]

Total Liabilities
Current Liabilities	[]
Non-current Liabilities	[]
Total Liabilities	[]

Total Shareholders' equity
Common Stock	[]
Retained Earnings	[]
Other Stockholders' Equity	[]
Total Shareholders' equity	[]

Total Liabilities & Shareholders Equity	[]


Total Assets
Current Assets	[]
Non-current Assets	[]
Total Assets	[]

Total Liabilities
Current Liabilities	[]
Non-current Liabilities	[]
Total Liabilities	[]

Total Shareholders' equity
Common Stock	[]
Retained Earnings	[]
Other Stockholders' Equity	[]
Total Shareholders' equity	[]

Total Liabilities & Shareholders Equity	[]

	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	(18.23M)	(21.32M)	[{"date":"2023-12-31","value":-1823300000,"profit":false},{"date":"2024-12-31","value":-2131900000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	150.00K	6.91M	[{"date":"2023-12-31","value":2.17,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	(28.68M)	(3.20M)	[{"date":"2023-12-31","value":-2868500000,"profit":false},{"date":"2024-12-31","value":-320300000,"profit":false}]

Free Cash Flow
Free Cash Flow	(18.54M)	(21.32M)	[{"date":"2023-12-31","value":-1853800000,"profit":false},{"date":"2024-12-31","value":-2131900000,"profit":false}]

	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	-	16.93%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	4504.00%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	(88.83%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	15.00%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	IMA
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	IMA
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is ImageneBio, Inc. share price today?

ImageneBio, Inc. (IMA) share price today is $7.96

Can Indians buy ImageneBio, Inc. shares?

Yes, Indians can buy shares of ImageneBio, Inc. (IMA) on Vested. To buy ImageneBio, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IMA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of ImageneBio, Inc. be purchased?

Yes, you can purchase fractional shares of ImageneBio, Inc. (IMA) via the Vested app. You can start investing in ImageneBio, Inc. (IMA) with a minimum investment of $1.

How to invest in ImageneBio, Inc. shares from India?

You can invest in shares of ImageneBio, Inc. (IMA) via Vested in three simple steps:

Click on Sign Up or Invest in IMA stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in ImageneBio, Inc. shares

What is ImageneBio, Inc. 52-week high and low stock price?

The 52-week high price of ImageneBio, Inc. (IMA) is $23.28. The 52-week low price of ImageneBio, Inc. (IMA) is $8.24.

What is ImageneBio, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of ImageneBio, Inc. (IMA) is 0.00

What is the Market Cap of ImageneBio, Inc.?

The market capitalization of ImageneBio, Inc. (IMA) is $94.49M

What is ImageneBio, Inc.’s stock symbol?

The stock symbol (or ticker) of ImageneBio, Inc. is IMA

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets Private Beta

Managed Portfolios (Previously Vests)

Global Mutual Funds Join Waitlist

Global

Explore our India Diversification

INR Bonds

Alt FDs

ImageneBio, Inc., Common Stock

IMA

NAQ

$7.96

-$0.49

(-5.8%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About ImageneBio, Inc., Common Stock

Returns

Financials

Ratios

Asset Efficiency

Valuation

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²